If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
288.20    -3.80 (-1.30%)
Bid:
288.20
Ask:
288.60
Spread: 0.40 (0.139%)
Market Cap: £1.00b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Director/PDMR Shareholding

9 Sep 2013 15:03

RNS Number : 5530N
Breedon Aggregates Ld
09 September 2013
 



9 September 2013

BREEDON AGGREGATES LIMITED

("Breedon" or the "Company")

 

Directors' Dealings

 

The Company announces that Mr Peter Tom, Chairman, has exercised a put option over his 2,000 Management Participation Shares in the Company's subsidiary Marwyn Materials Investments Limited ("MP Shares") which were issued in 2008. Following Mr Tom's exercise of the put option over 2,000 MP Shares, it is expected that the MP Shares will be exchanged for 18,649,926 ordinary shares of nil par value in the Company ("Ordinary Shares").

 

The Company further announces that Mr Simon Vivian, Group Chief Executive, has exercised a put option over 2,000 MP Shares. Following Mr Vivian's exercise of the put option over 2,000 MP Shares it is expected that the MP Shares will be exchanged for 18,649,926 Ordinary Shares.

 

The Company further announces that Mr Ian Peters, Group Finance Director, has exercised a put option over 1,000 MP Shares. Following Mr Peters' exercise of the put option over 1,000 MP Shares it is expected that the MP Shares will be exchanged for 9,324,963 Ordinary Shares.

 

Following completion of the above exchanges no further MP Shares will remain outstanding, and each director is expected to have an interest in the number of Ordinary Shares set against their name below:

Name

Ordinary Shares held following the exchange

Percentage of Total Voting Rights following the exchange*

Peter Tom CBE

54,441,867

5.47%

Simon Vivian

21,519,647

2.16%

Ian Peters

11,337,348

1.14%

 

* Following the allotment, issue and admission of the new Ordinary Shares required to satisfy the above exchanges.

 

Enquiries:

 

Breedon Aggregates Limited

 

Simon Vivian, Group Chief Executive

01332 694010

 

Stephen Jacobs, Head of Communications

07831 764592

 

Cenkos Securities plc (NOMAD)

Max Hartley

020 7397 8900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFISAIIAIIV
Date   Source Headline
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.